Atlas FDA

DEXCON SEVEN AND SEVEN PLUS

FDA premarket approval P050012/S027 · decided 2010-11-16

Approval details

PMA number
P050012
Supplement
S027
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
DEXCON SEVEN AND SEVEN PLUS
Generic name
Sensor, glucose, invasive
Applicant
Dexcom, Inc.
Date received
2010-07-13
Decision date
2010-11-16
Days to decision
126 days
Decision code
APPR
Product code
MDS
Advisory committee
Clinical Chemistry
Expedited review
No
Location
San Diego, CA
Statement
APPROVAL FOR A REDUCTION IN STANDOFF AS WELL AS ADDITION OF SHOCK MOUNTING ON THE RECEIVER UNIT OF THE DEVICE.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Stelo Glucose Biosensor System (K260935)Dexcom, Inc.2026-06-12
Dexcom G7 Continuous Glucose Monitoring System;Dexcom G7 15 Day Continuous Glucose Monitoring System (K261402)Dexcom, Inc.2026-06-08
Stelo Glucose Biosensor System (K261359)Dexcom, Inc.2026-05-21
Dexcom G7 Continuous Glucose Monitoring (CGM) System; Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System (K253737)Dexcom, Inc.2026-02-03
Dexcom G7 Continuous Glucose Monitoring (CGM) System, Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System (K253710)Dexcom, Inc.2025-12-17
Dexcom Smart Basal (K252818)Dexcom, Inc.2025-11-18
Dexcom G7 15 Day Continuous Glucose Monitoring System (K243214)Dexcom, Inc.2025-04-09
Dexcom G7 Continuous Glucose Monitoring System (K240902)Dexcom, Inc.2024-04-23